ArticleScientific reports2025
Using Phantomless QCT for evaluating BMD evolution in maintenance hemodialysis patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study was aimed to investigate the evolution of bone mineral density (BMD) in patients with maintenance hemodialysis (MHD) by using phantom-less quantitative computed tomography (PL-QCT). We collected patients with MHD in Suzhou Hospital of Nanjing Medical University from September 2020 to December 2023 as the prospective observation group. BMD of thoracolumbar vertebra, total hip and femoral neck were measured by PL-QCT. Patients with MHD were divided into 9 groups according to hemodialysis duration. Chest CT scans of patients in prospective observation group were collected during the first three months of MHD and 1 year, 2 years, 3 years after dialysis between January 2017 and December 2023 as the retrospective observation group, and BMD of the twelfth thoracic vertebra was measured. According to the BMD changes among the prospective observation group and the retrospective observation group, the evolution of thoracolumbar vertebral BMD, whole hip BMD and femoral neck BMD were comprehensively analyzed. BMD of thoracolumbar vertebra gradually decreased within 36 months in patients with MHD. Thoracolumbar vertebral BMD tended to increase when hemodialysis duration was more than 36-48 months, and thoracolumbar vertebral BMD increased significantly with hemodialysis duration when hemodialysis duration was more than 60 months, and significantly exceeded the BMD before MHD. BMD of total hip and femoral neck gradually decreased within 36 months in patients with MHD. BMD of total hip and femoral neck increased with hemodialysis duration when hemodialysis duration was more than 72 months, but was almost the same as that of the first year of MHD. In the follow-up evaluation of BMD in MHD patients, it is recommended to use QCT to measure BMD in thoracolumbar vertebrae or hip the first 3 years of MHD, and use QCT to measure BMD in thoracolumbar vertebrae to evaluate changes over 5 years of MHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.